# Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer

> **NCT07526675** · NA · NOT_YET_RECRUITING · sponsor: **Benha University** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer
- Lower Urinary Tract Symptoms (LUTS)
- Benign Prostatic Hyperplasia

## Interventions

- **PROCEDURE:** Bioblation

## Key facts

- **NCT ID:** NCT07526675
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2026-04-20
- **Final completion:** 2026-04-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07526675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07526675, "Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07526675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*